Arrowhead Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Arrowhead Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 99% to $3,551,000. Profit margin reached -16882%. Total operating expenses were $604,631,000.
Profit Margin
| 2015 | 382K | -91.94M | -24068.29% |
|---|---|---|---|
| 2016 | 158.33K | -81.72M | -51614.64% |
| 2017 | 31.40M | -34.38M | -109.46% |
| 2018 | 16.14M | -54.45M | -337.32% |
| 2019 | 168.79M | 67.97M | 40.27% |
| 2020 | 87.99M | -84.55M | -96.09% |
| 2021 | 138.28M | -140.84M | -101.85% |
| 2022 | 243.23M | -176.49M | -72.56% |
| 2023 | 240.73M | -205.27M | -85.27% |
| 2024 | 3.55M | -599.49M | -16882.37% |
ARWR Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 3.55M | 240.73M | 243.23M | 138.28M | 87.99M | 168.79M | 16.14M | 31.40M | 158.33K | 382K |
Cost of revenue | 0 | 0 | 10.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 3.55M | 240.73M | 232.81M | 138.28M | 87.99M | 168.79M | 16.14M | 31.40M | 158.33K | 382K |
Operating exp. | ||||||||||
Research and development | 505.87M | 353.18M | 297.30M | 206.34M | 128.87M | 81.04M | 52.96M | 31.69M | 41.45M | 57.41M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 604.63M | 445.73M | 421.73M | 287.32M | 181.15M | 107.60M | 72.07M | 68.40M | 79.85M | 96.35M |
Operating income | -601.08M | -205.00M | -178.50M | -149.03M | -93.15M | 61.19M | -55.93M | -36.99M | -81.74M | -95.97M |
Other income (expenses), net | -11.38M | -1.48M | 5.79M | 8.19M | 8.60M | 6.95M | 439.63K | 2.61M | -2.29M | 4.03M |
Income before tax | -612.46M | -206.49M | -172.70M | -140.84M | -84.55M | 68.14M | -54.44M | -34.37M | -81.72M | -91.93M |
Income tax expense | -2.76M | 2.78M | 3.78M | 2K | 2.4K | 173.55K | 2.4K | 2.4K | 2.4K | 2.4K |
Net income | -599.49M | -205.27M | -176.49M | -140.84M | -84.55M | 67.97M | -54.45M | -34.38M | -81.72M | -91.94M |
Earnings per share | ||||||||||
Basic EPS | -5 | -1.91 | -1.67 | -1.36 | -0.84 | 0.72 | -0.65 | -0.47 | -1.34 | -1.6 |
Diluted EPS | -5 | -1.92 | -1.67 | -1.36 | -0.84 | 0.69 | -0.65 | -0.47 | -1.34 | -1.6 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |